跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Herceptin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Herceptin
Approved
STANDARD
Herceptin
F. Hoffman-La Roche AG
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a31095582d4a7bb2
Company
F. Hoffman-La Roche AG
Type
Standard
Approval Details
Approval Id
a31095582d4a7bb2
Drug Approval Philippines Name
Herceptin
Product Name
Herceptin
Registration Number
BR-1121
Brand Name
Herceptin
Generic Name
Trastuzumab
Dosage Form
Solution for Injection (SC)
Dosage Strength
600 mg/5 mL (120 mg/mL)
Manufacturer
F. Hoffman-La Roche AG
Issuance Date
26 February 2025
Expiry Date
26 February 2030
Pharmacologic Category
Antineoplastic Agents [HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors]
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a31095582d4a7bb2
Type
Standard
Back to Philippines FDA Approvals